Novelix Pharmaceuticals EGM Approves Preferential Share Issue

Novelix Pharmaceuticals Ltd held an Extra Ordinary General Meeting (EGM) on July 01, 2026, via video conferencing. The primary business was the issue of equity shares on a preferential basis. The resolution passed with overwhelming support, with 10,517,783 votes in favour and only 10 votes against, out of a total of 10,511,193 votes polled. The meeting was conducted electronically, and voting results were submitted along with the consolidated scrutinizer's report. The total number of shareholders as of the cutoff date was 3235.